No association between Apolipoprotein E ε4 allele and rate of decline in Alzheimer's disease

American Journal of Psychiatry

Volumn 154, Issue 5, 1997, Pages 603-608

  Murphy Jr , Greer M ^a   Taylor, Joy ^b   Kraemer, Helena C ^b   Yesavage, Jerome ^b   Tinklenberg, Jared R ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; DEMENTIA; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR;

EID: 1842298766     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.5.603     Document Type: Article

References (48)

1. Jorm AF: Subtypes of Alzheimer's dementia: a conceptual analysis and critical review. Psychol Med 1985; 15:543-553
2. Chui HC, Teng EL, Henderson MD, Moy AC: Clinical subtypes of dementia of the Alzheimer type. Neurology 1985; 35:1544-1550
3. Ritchie K, Touchon J: Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical subtypes. J Clin Epidemiol 1992; 45:1391-1398
4. Strittmatter WJ, Roses AD: Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 1995; 92:4725-4727
5. Farrer L, Brin MF, Elsas L, Goate A, Kennedy J, Mayeux R, Myers RH, Reilly P, Risch NJ: Statement on the use of apolipoprotein E testing for Alzheimer's disease. JAMA 1995; 274:1627-1629
6. Brooks JO III, Yesavage JA: Identification of fast and slow decliners in Alzheimer's disease: a different approach. Alzheimer Dis Assoc Disord 1995; 9(suppl 1):S19-S25
7. Corder E, Saunders A, Strittmatter W, Schmechel D, Gaskell P, Rimmler JB, Locke BA, Conneally PM, Schmader KE, Tanzi RE, Gusella JF, Small GW, Roses AD, Pericak-Vance MA, Haines JL: Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995; 45:1323-1328
8. Norrman J, Brookes AJ, Yates C, St Clair D: Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease. Br J Psychiatry 1995; 167:533-536
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
10. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
11. Gearing M, Schneider JA, Rebeck GW, Hyman BT, Mirra SS: Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology 1995; 45:1985-1990
12. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM: Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 1994; 145:1472-1484
13. Pickering-Brown SM, Mann DMA, Bourke JP, Roberts DA, Balderson D, Burns A, Byrne J, Owen F: Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other β-amyloid-forming diseases (letter). Lancet 1994; 343:1155
14. St Clair D, Norrman J, Perry R, Yates C, Wilcock G, Brookes A: Apolipoprotein E ε4 allele frequency in patients with Lewy body dementia, Alzheimer's disease, and age-matched controls. Neurosci Lett 1994; 176:45-46
15. Kraemer HC, Thiemann S: A strategy to use "soft" data effectively in randomized clinical trials. J Consult Clin Psychol 1989; 57:148-154
16. Lahiri DK, Nurnberger JI Jr: A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19:5444
17. Richards B, Skoletsky J, Shuber AP, Balfour R, Stern R, Dorkin H, Parad R, Witt D, Klinger K: Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/ swabs. Hum Mol Genet 1993; 2:159-163
18. Greer CE, Wheeler CM, Manos MM: Sample preparation and PCR amplification from paraffin-embedded tissues. PCR Methods Appl 1994; 3:S113-S122
19. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31:545-548
20. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop P, Pericak-Vance M, Joo S, Rosi B, Gusella JF, Crapper-Mac-Lachlan D, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses A: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-1472
21. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel D, Gaskell P, Rimmler J, Locke P, Conneally P, Schmader K, Small G, Roses A, Haines J, Pericak-Vance M: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994; 7:180-184
22. Frisoni G, Govoni S, Geroldi C, Bianchetti A, Calabresi L, Franceshini G, Trabucchi M: Gene dose of the ε4 allele in apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 1995; 37:596-604
23. Dal Forno G, Rasmusson DX, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH: Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 1996; 53:345-350
24. Basun H, Grut M, Winblad B, Lannfelt L: Apolipoprotein ε4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995; 183:32-34
25. Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT: Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Ann Neurol 1996; 39:62-70
26. Brooks JO III, Kraemer HC, Tanke ED, Yesavage JA: The methodology of studying decline in Alzheimer's disease. J Am Geriatr Soc 1993; 41:623-628
27. Burns A, Jacoby R, Levy R: Progression of cognitive impairment in Alzheimer's disease. J Am Geriatr Soc 1991; 39:39-45
28. Galasko D, Corey-Bloom J, Thal LJ: Monitoring progression in Alzheimer's disease. J Am Geriatr Soc 1991; 39:932-941
29. Salmon DP, Thal LJ, Butters N, Heindel WC: Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology 1990; 40: 1225-1230
30. van Belle G, Uhlmann RF, Hughes JP, Larson EB: Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer type. J Clin Epidemiol 1990; 43:589-595
31. Yesavage JA, Poulsen SL, Sheikh JI, Tanke ED: Rates of change of common measures of impairment in senile dementia of the Alzheimer's type. Psychopharmacol Bull 1988; 24:531-534
32. Gibbons RD, Hedeker D, Waternaux C, Kraemer HC, Greenhouse JB: Some conceptual and statistical issues in the analysis of longitudinal psychiatric data. Arch Gen Psychiatry 1993; 50: 739-750
33. Kraemer HC: Reporting the size of effects in research studies to facilitate assessment of practical or clinical significance. Psychoneuroendocrinology 1993; 17:527-536
34. Rebeck G, Reiter J, Strickland D, Hyman BT: Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11:575-580
35. Schmechel D, Saunders A, Strittmatter W, Crain B, Hulette C, Joo S, Pericak-Vance M, Goldgaber D, Roses A: Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90:9649-9653
36. Neary D, Snowden JS, Mann DMA, Bowen DM, Sims NR, Northen B, Yates P, Davison A: Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry 1986; 49:229-237
37. Terry R, Masliah E, Salmon P, Butters N, DeTeresa R, Hill R, Hansen L, Katzman R: Physical basis of cognitive decline alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30:572-580
38. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375:754-760
39. Van Broeckhoven C, Backhovens H, Cruts M, Martin J, Crook R, Houlden H, Hardy J: APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994; 169:179-180
40. Levy-Lahad E, Lahad A, Wijsman EM, Bird TD, Schellenberg GD: Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease. Ann Neurol 1995; 38:678-680
41. Miller TP, Tinklenberg JR, Brooks JO, Yesavage J: Cognitive decline in patients with Alzheimer's disease: differences in patients with and without extrapyramidal signs. Alzheimer Dis Assoc Disord 1991; 5:251-256
42. Miller TP, Tinklenherg JR, Brooks JO, Fenn HH, Yesavage JA: Selected psychiatric symptoms are associated with rate of cognitive decline in patients with Alzheimer's disease. J Geriatr Psychiatry Neurol 1993; 6:235-238
43. Teri L, Hughes JP, Larson EB: Cognitive deterioration in Alzheimer's disease: behavioral and health factors. J Gerontol 1990; 45:P58-P63
44. St Clair D, Rennie M, Slorach E, Norrman J, Yates C, Carothers A: Apolipoprotein E ε4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers. J Med Genet 1995; 32:642-644
45. Van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C: Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994; 7:74-78
46. Zubenko GS, Stiffler S, Stabler S, Kopp U, Hughes H, Cohen B, Moossy J: Association of the apolipoprotein E ε4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet 1994; 54:199-205
47. Roses A: Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995; 38: 6-14
48. Bird T: Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol 1995; 38:2-4